“…Metastasis is a complicated process in which distal tumor dissemination occurs after cancer cells in the primary tumor experience epithelial–mesenchymal transition (EMT) to disrupt intercellular junctions, reorganize the actin cytoskeleton, and increase cell motility for initial cancer cell spreading (Sarrió et al, 2008). Several stromal and endocrine growth factors, including insulin-like growth factor I (IGF-1), fibroblast growth factor, EGF, and angiogenin (ANG), regulate ACTN or ACTN4 binding to its cytoskeletal working partners and hence result in cell morphological changes and cytoskeletal reorganization, both of which may facilitate the metastatic process (Guvakova, Adams, & Boettiger, 2002; Shao, Wu, et al, 2010; Vandermoere et al, 2007; Wei, Gao, Du, Su, & Xu, 2011). In most breast cancers, the separation of invasive carcinoma from nearby adherent epithelium is an early step for metastases.…”